Significant Estimated Glomerular Filtration Rate Reduction After Robotic Partial Nephrectomy
This online nomogram predicts the loss of renal function after partial nephrectomy for renal cancer.
Research authors: Alberto Martini, Shivaram Cumarasamy, Alp Tuna Beksac, Romney Abaza, Daniel D. Eun, Akshay Bhandari, Ashok K. Hemal, James R. Porter, Ketan K. Badan
Details Custom formula Study characteristics Files & References
★★★
Model author
Model ID
1602
Version
1.16
Revision date
2018-11-08
MeSH terms
  • Nephrectomy
  • Kidney Cancer
  • Renal Cancer
  • Acute Kidney Injury
  • Chronic Kidney Disease
  • Model type
    Cox regression (Calculation)
    Status
    public
    Rating
    Share
    Formula
    No Formula defined yet
    Condition Formula

    Additional information

    The model was developed using data from 999 patients who underwent robot-assisted partial nephrectomy (RAPN). In total, 146 patients experienced significant eGFR reduction. 

    The model was fitted using cox-regression and was validated using leave-one-out cross validation

    Study Population

    Total population size: 999
    Males: {{ model.numberOfMales }}
    Females: {{ model.numberOfFemales }}

    Continuous characteristics

    Name LL Q1 Median Q3 UL Unit
    Age 51 61 68 years
    Body Mass Index 26 29 34 kg/m2
    Baseline eGFR 66 82 96 ml/min/1.73m2
    RENAL score 6 7 9 points
    Ischemia time 11 15 20 min

    Categorical characteristics

    Name Subset / Group Nr. of patients
    Race Caucasian 908
    African American 64
    Other 27
    Hypertension No 565
    Yes 426
    Charlson Comorbidity Index 0 516
    1 253
    2 153
    3 53
    ≥4 24
    Baseline GFR category 1 358
    2 459
    3a 127
    3b 46
    4 9
    Acute Kidney njury No 805
    Yes 195
    Pathological T stage 1a 798
    1b 141
    2a 10
    2b 2
    3a 48

    Related files

    Risk for ≥25% reduction from baseline estimated glomerular filtration rate is:
    ...

    {{ resultSubheader }}

    {{ model.survival.PITTitle }}

    {{ model.survival.YNETitle }}

    Result
    Note
    Notes are only visible in the result download and will not be saved by Evidencio

    Risk for ≥25% reduction from baseline estimated glomerular filtration rate is:

    {{ resultSubheader }}

    Outcome stratification

    Result interval {{ additionalResult.min }} to {{ additionalResult.max }}

    Conditional information

    Result interpretation

    The nomogram predicts significant eGFR reduction ≥25% from baseline in the time-frame between 3 and 15 months after robot-assisted partial nephrectomy. 

    On internal validation, the model showed a c-statistic of 0.73

    Decision curve analysis (see image below) showed that the model contributes to clinical benefits with probabilities ≥4%

    To improve medical decision making, this model requires external validation and should be validated in open and laparoscopic patients as well. 

    {{ file.classification }}

    Calculations alone should never dictate patient care, and are no substitute for professional judgement. See our full disclaimer.

    Comments
    Rating
    Comment
    Please enter a comment of rating
    Comments are visible to anyone

    Model feedback

    No feedback yet 1 Comment {{ model.comments.length }} Comments
    Not rated | On {{ comment.created_at }} {{ comment.user.username }} a no longer registered author wrote:
    {{ comment.content }}
    logo

    Please sign in to enable Evidencio print features

    In order to use the Evidencio print features, you need to be logged in.
    If you don't have an Evidencio Community Account you can create your free personal account at:

    https://www.evidencio.com/registration

    Printed results - Examples {{ new Date().toLocaleString() }}


    Evidencio Community Account Benefits


    With an Evidencio Community account you can:

    • Create and publish your own prediction models.
    • Share your prediction models with your colleagues, research group, organization or the world.
    • Review and provide feedback on models that have been shared with you.
    • Validate your models and validate models from other users.
    • Find models based on Title, Keyword, Author, Institute, or MeSH classification.
    • Use and save prediction models and their data.
    • Use patient specific protocols and guidelines based on sequential models and decision trees.
    • Stay up-to-date with new models in your field as they are published.
    • Create your own lists of favorite models and topics.
    A personal Evidencio account is free, with no strings attached! Join us and help create clarity, transparency, and efficiency in the creation, validation, and use of medical prediction models.

    Disclaimer: Calculations alone should never dictate patient care, and are no substitute for professional judgement.